XML 31 R44.htm IDEA: XBRL DOCUMENT
v3.20.1

Share capital (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Disclosure of reserves within equity [abstract] |
Schedule of changes in share capital |
|  | Class A shares |  |  | Class B shares |  |  | Warrants |
|  | # |  |  | $ |  |  | # |  |  | $ |  |  | # |  |  | $ |
Balance, December 31, 2017 |  | 72 |  |  | 201,500 |  |  | 3,794,846 |  |  | 12,794,963 |  |  | 354,996 |  |  | 2,116,900 |
Share issued |  | — |  |  | — |  |  | 2,268,035 |  |  | 47,853,745 |  |  | — |  |  | — |
Share issuance costs |  | — |  |  | — |  |  | — |  |  | (6,634,405 | ) |  | — |  |  | — |
Reverse acquisition |  | — |  |  | — |  |  | 545,505 |  |  | 9,868,179 |  |  | 37,313 |  |  | 118,875 |
Warrant valuations |  | — |  |  | — |  |  | — |  |  | (2,366,670 | ) |  | 198,835 |  |  | 2,366,670 |
Share-based payments |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 294,287 |
Share options exercised |  | — |  |  | — |  |  | 190,463 |  |  | 5,145,825 |  |  | — |  |  | — |
Share options cancelled |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Warrants exercised |  | — |  |  | — |  |  | 44,931 |  |  | 1,254,665 |  |  | (44,932 | ) |  | (454,587 | )
Balance, December 31, 2018 |  | 72 |  |  | 201,500 |  |  | 6,843,780 |  |  | 67,916,302 |  |  | 546,212 |  |  | 4,442,145 |
Balance, December 31, 2018 |  | 72 |  |  | 201,500 |  |  | 6,843,780 |  |  | 67,916,302 |  |  | 546,212 |  |  | 4,442,145 |
Shares issued [a] [b] [c] [d] [e] |  | — |  |  | — |  |  | 408,651 |  |  | 11,539,417 |  |  | — |  |  | — |
Issued on acquisition of net assets of Prismic |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Pharmaceuticals, Inc. [f] |  | — |  |  | — |  |  | 510,940 |  |  | 16,431,818 |  |  | 67,598 |  |  | 1,888,086 |
Share options exercised |  | — |  |  | — |  |  | 130,189 |  |  | 1,782,438 |  |  | — |  |  | — |
Warrants exercised |  | — |  |  | — |  |  | 12,167 |  |  | 145,174 |  |  | (12,167 | ) |  | (50,183 | )
Warrants expired |  | — |  |  | — |  |  | — |  |  | — |  |  | (134,192 | ) |  | (535,014 | )
Balance, December 31, 2019 |  | 72 |  |  | 201,500 |  |  | 7,905,727 |  |  | 97,815,149 |  |  | 467,451 |  |  | 5,745,034 |
Disclosure of changes in warrants outstanding and weighted average exercise price |
|  | Number of warrants |  |  | Weighted average exercise price
|  | # |  |  | $
Outstanding as at December 31, 2017 |  | 354,996 |  |  | 5.80
Granted |  | 236,148 |  |  | 16.57
Exercised |  | (44,932 | ) |  | 17.79
Outstanding as at December 31, 2018 |  | 546,212 |  |  | 9.47
Granted |  | 67,598 |  |  | 10.45
Exercised |  | (12,167 | ) |  | 7.81
Expired |  | (134,192 | ) |  | 7.64
Outstanding as at December 31, 2019 |  | 467,451 |  |  | 10.20
Disclosure of fair value assumptions of warrants outstanding |
| 2019 | 2018
Grant date share price | $32.16 | $4.42 - $18.09
Exercise price | $2.61 - $26.73 | $4.42 - $26.13
Expected dividend yield | — | —
Risk free interest rate | 1.41% - 1.52% | 1.70% - 2.17%
Expected life | 1.39 - 6.55 | 2 years
Expected volatility | 100% | 100%
Disclosure of number of warrants outstanding and exercise price | The following table is a summary of the Company's warrants outstanding as at December 31, 2019: Warrants Outstanding
|  | Exercise price |  |  | Number outstanding
Expiry Date |  | $ |  |  | #
November 30, 2020 |  | 2.61 |  |  | 16,787
September 15, 2022 |  | 4.42 |  |  | 199,005
August 1, 2021 |  | 5.43 |  |  | 4,476
September 11, 2023 |  | 5.43 |  |  | 22,382
January 5, 2020 |  | 6.03 |  |  | 37,313
July 24, 2023 |  | 13.07 |  |  | 3,357
May 20, 2023 |  | 16.08 |  |  | 7,311
May 24, 2022 |  | 18.09 |  |  | 163,535
May 4, 2025 |  | 26.73 |  |  | 3,730
May 10, 2025 |  | 26.73 |  |  | 1,865
May 17, 2025 |  | 26.73 |  |  | 3,730
May 31, 2025 |  | 26.73 |  |  | 1,865
January 16, 2026 |  | 26.73 |  |  | 1,722
January 20, 2026 |  | 26.73 |  |  | 373
|  | 10.20 |  |  | 467,451
The following table is a summary of the Company's warrants outstanding as at December 31, 2018: Warrants Outstanding
|  | Exercise price |  |  | Number outstanding
Expiry Date |  | $ |  |  | #
September 15, 2022 |  | 4.42 |  |  | 199,005
October 20, 2019 |  | 7.56 |  |  | 11,970
November 1, 2019 |  | 7.56 |  |  | 69,240
November 14, 2019 |  | 7.56 |  |  | 52,532
November 21, 2019 |  | 7.56 |  |  | 10,263
December 12, 2019 |  | 7.56 |  |  | 1,084
December 29, 2019 |  | 7.56 |  |  | 1,072
January 5, 2020 |  | 6.03 |  |  | 37,313
May 24, 2022 |  | 18.09 |  |  | 163,733
|  | 9.47 |  |  | 546,212

X
- Definition Represents the tabular disclosure of changes in warrants outstanding and weighted average exercise price. + References No definition available. + Details
Name: | huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory
Namespace Prefix: | huge_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the tabular disclosure of fair value assumption of warrants outstanding. + References No definition available. + Details
Name: | huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory
Namespace Prefix: | huge_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the tabular disclosure of number of warrants outstanding and exercise price. + References No definition available. + Details
Name: | huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory
Namespace Prefix: | huge_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of classes of share capital. [Refer: Share capital [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2019-01-01 -Paragraph 79 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_79_a&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfReservesWithinEquityAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration